Glomerular Disease

Glomerulonephritis Consortium

Olga Zhdanova, MD

The NYU Division of Nephrology is part of a multi-institutional glomerulornephritis consortium that will address the impact of various therapeutic interventions in randomized trials in seven different glomerular diseases. R33 grant applications will be submitted to NIDDK/NIH between March and December 2004 for new therapeutic trials including:

  1. Membranous glomerulopathy
  2. Idiopathic FSGS
  3. Recurrent FSGS in transplant
  4. IgA nephropathy
  5. Lupus nephritis
  6. ANCA associated vasculitis
  7. Chronic sclerosing renal disease